Lam Research Corporation vs Tenet Healthcare Corporation — how do they compare? Lam Research Corporation trades at $319.67 (market cap $389.67B), while Tenet Healthcare Corporation trades at $259.45 (market cap $20.89B). The key difference: Lam Research Corporation is far larger — about 18.7× Tenet Healthcare Corporation's market cap, and Lam Research Corporation pays a 0.33% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.
| LRCX | THC | |
|---|---|---|
Market Cap | $389.67B | $20.89B |
Sector | Technology | Health |
52-Week High | $433.33 | $262.63 |
52-Week Low | $97.03 | $161.37 |
Enterprise Value | $387.83B | $31.97B |
Dividend Yield | 0.33% | — |
Trailing returns across standard periods
Latest headlines on both assets
Lam Research manufactures equipment used to fabricate semiconductors. The firm is focused on the etching, deposition, and clean markets, which are key steps in the semiconductor manufacturing process, especially for 3D NAND flash storage, advanced DRAM, and leading-edge logic/foundry chipmakers. Lam's flagship Kiyo, Vector, and Sabre products are sold in all major geographies to key customers such as Samsung Electronics, Micron, Intel, and Taiwan Semiconductor Manufacturing.
Read more on LRCX →Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →